Related Experiment Videos
Chlorambucil carcinogenesis in BALB/c mice
A Cavaliere1, N Pietropaoli, P F Alberti
1Institute of Pathological Anatomy and Histology, Perugia University, Italy.
Cancer Letters
|December 3, 1990
Summary
Chlorambucil administration significantly reduced survival and increased tumor incidence in mice. This study suggests chlorambucil is a potential carcinogenic hazard to humans.
Area of Science:
- Oncology
- Toxicology
- Carcinogenesis
Background:
- Chlorambucil is a chemotherapy agent used for neoplastic and non-neoplastic diseases.
- Assessing the long-term carcinogenic potential of chlorambucil is crucial for human health risk evaluation.
Purpose of the Study:
- To evaluate the carcinogenicity of chlorambucil in BALB/c mice.
- To determine the impact of chlorambucil on survival and tumor development.
Main Methods:
- BALB/c mice were administered chlorambucil (1.0 mg/kg body weight) five times per week for 12 weeks.
- Survival rates and tumor incidence (lung, lymphoreticular system, mammary) were statistically analyzed.
Main Results:
- Chlorambucil treatment led to a statistically significant reduction in survival for both male and female mice (P < 0.001).
- A significant increase in lung tumors (P < 0.001) and lymphoreticular system tumors (P < 0.01 for males, P < 0.001 for females) was observed in both sexes.
- Female mice also showed a significant increase in mammary carcinomas (P < 0.05).
Conclusions:
- The findings indicate that chlorambucil is carcinogenic in laboratory animals.
- Chlorambucil's mutagenic properties and potential carcinogenic hazard to humans are supported by these results and existing literature.